The Company

Kalaco Scientific, Inc. (Kalaco) designs and manufactures leading-edge Transcranial Electrical Stimulation (TES) equipment that is safe and effective. Kalaco is a medical device company that plans to open therapy centers world-wide with its proprietary and patented Nexalin® Technology and is currently registered with the FDA for export only. We have already opened our first therapy center in Germany.

Kalaco is a 5 ½ year-old company committed to advancing the Nexalin Technology through continued scientific research, discovering alternate treatments for ailments afflicting people today and tomorrow. Kalaco is a Nevada corporation with accredited stockholders across the United States.

Kalaco currently has clearance in the United States for Anxiety, Depression, and Insomnia. Other intended uses are approved in other countries, but not yet in the United States and require investigation and FDA market authorization before the Nexalin™ technology can be offered for those uses.